Alkermes PLC (ALKS) Receives $61.50 Consensus PT from Analysts

Alkermes PLC (ALKS) Receives $61.50 Consensus PT from Analysts


Shares of Alkermes PLC have been given an average recommendation of "Buy" by the thirteen research firms that are currently covering the firm. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company.



from Biotech News